Revision as of 23:05, 20 December 2024 editLaura240406 (talk | contribs)Extended confirmed users1,010 editsm →See also: remove self redirect← Previous edit | Latest revision as of 23:39, 10 January 2025 edit undoArthurfragoso (talk | contribs)Extended confirmed users, Template editors4,591 edits dark mode fix | ||
Line 5: | Line 5: | ||
| verifiedrevid = 451725338 | | verifiedrevid = 451725338 | ||
| ImageFile = Clonixin.png | | ImageFile = Clonixin.png | ||
| ImageClass = skin-invert-image | |||
| PIN = 2-(3-Chloro-2-methylanilino)pyridine-3-carboxylic acid | | PIN = 2-(3-Chloro-2-methylanilino)pyridine-3-carboxylic acid | ||
| OtherNames = Clonixic acid; CBA 93626<ref name="Clinical">{{cite journal|url=http://onlinelibrary.wiley.com/doi/10.1177/009127007101100508/abstract|title=Clonixin: A Clinical Evaluation of a New Oral Analgesic |journal=The Journal of Clinical Pharmacology and New Drugs |volume=11 |issue=5 |pages=371–377 |access-date=2015-05-21|doi=10.1177/009127007101100508|pmid=4935715 |year=1971 |last1=Finch |first1=Jay S. |last2=Dekornfeld |first2=Thomas J. |hdl=2027.42/67636 |s2cid=38883141 |hdl-access=free }}</ref> | | OtherNames = Clonixic acid; CBA 93626<ref name="Clinical">{{cite journal|url=http://onlinelibrary.wiley.com/doi/10.1177/009127007101100508/abstract|title=Clonixin: A Clinical Evaluation of a New Oral Analgesic |journal=The Journal of Clinical Pharmacology and New Drugs |volume=11 |issue=5 |pages=371–377 |access-date=2015-05-21|doi=10.1177/009127007101100508|pmid=4935715 |year=1971 |last1=Finch |first1=Jay S. |last2=Dekornfeld |first2=Thomas J. |hdl=2027.42/67636 |s2cid=38883141 |hdl-access=free }}</ref> | ||
Line 63: | Line 64: | ||
==Synthesis== | ==Synthesis== | ||
]).]] | ]).]] | ||
==Clonixeril== | ==Clonixeril== | ||
The glyceryl ester of clonixin, clonixeril, is also an NSAID. It was prepared by a somewhat roundabout method. | The glyceryl ester of clonixin, clonixeril, is also an NSAID. It was prepared by a somewhat roundabout method. | ||
] | ] | ||
Clonixin was reacted with ] and ] to give '''2'''. Heating with ] and ] displaced the ] to produce ester '''3''', which was deblocked in ] to produce clonixeril ('''4'''). | Clonixin was reacted with ] and ] to give '''2'''. Heating with ] and ] displaced the ] to produce ester '''3''', which was deblocked in ] to produce clonixeril ('''4'''). | ||
Latest revision as of 23:39, 10 January 2025
Nonsteroidal anti-inflammatory drug (NSAID)Names | |
---|---|
Preferred IUPAC name 2-(3-Chloro-2-methylanilino)pyridine-3-carboxylic acid | |
Other names Clonixic acid; CBA 93626 | |
Identifiers | |
CAS Number | |
3D model (JSmol) | |
ChEBI | |
ChEMBL | |
ChemSpider | |
ECHA InfoCard | 100.037.921 |
KEGG | |
PubChem CID | |
UNII | |
CompTox Dashboard (EPA) | |
InChI
| |
SMILES
| |
Properties | |
Chemical formula | C13H11ClN2O2 |
Molar mass | 262.69 g·mol |
Pharmacology | |
Routes of administration |
per os |
Pharmacokinetics: | |
Metabolism | Glucuronidation via UGT2B7 |
Legal status |
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C , 100 kPa). N verify (what is ?) Infobox references |
Clonixin is a nonsteroidal anti-inflammatory drug (NSAID). It also has analgesic, antipyretic, and platelet-inhibitory actions. It is used primarily in the treatment of chronic arthritic conditions and certain soft tissue disorders associated with pain and inflammation.
Synthesis
Clonixeril
The glyceryl ester of clonixin, clonixeril, is also an NSAID. It was prepared by a somewhat roundabout method.
Clonixin was reacted with chloroacetonitrile and triethylamine to give 2. Heating with potassium carbonate and glycerol acetonide displaced the activating group to produce ester 3, which was deblocked in acetic acid to produce clonixeril (4).
See also
References
- Finch, Jay S.; Dekornfeld, Thomas J. (1971). "Clonixin: A Clinical Evaluation of a New Oral Analgesic". The Journal of Clinical Pharmacology and New Drugs. 11 (5): 371–377. doi:10.1177/009127007101100508. hdl:2027.42/67636. PMID 4935715. S2CID 38883141. Retrieved 2015-05-21.
- M. H. Sherlock, ZA 6802185 (1968); Chem. Abstr., 70: 96640c (1969).
- CH 534129 (1973); Chem. Abstr., 79: 18582g (1973).
This drug article relating to the musculoskeletal system is a stub. You can help Misplaced Pages by expanding it. |